Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up
- PMID: 11422435
- DOI: 10.1046/j.1468-1331.2001.00224.x
Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up
Comment in
-
Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease after treatment with galantamine.Eur J Neurol. 2002 Sep;9(5):545. doi: 10.1046/j.1468-1331.2002.04455.x. Eur J Neurol. 2002. PMID: 12220392 No abstract available.
Similar articles
-
Rivastigmine in vascular dementia.Expert Opin Pharmacother. 2004 Jun;5(6):1399-410. doi: 10.1517/14656566.5.6.1399. Expert Opin Pharmacother. 2004. PMID: 15163283 Review.
-
Rivastigmine in subcortical vascular dementia: an open 22-month study.J Neurol Sci. 2002 Nov 15;203-204:141-6. doi: 10.1016/s0022-510x(02)00280-0. J Neurol Sci. 2002. PMID: 12417373 Clinical Trial.
-
Role of cholinesterase inhibitor in the management of sexual aggression in an elderly demented woman.J Am Geriatr Soc. 2003 Sep;51(9):1326. doi: 10.1046/j.1532-5415.2003.514204.x. J Am Geriatr Soc. 2003. PMID: 12919253 No abstract available.
-
Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients.Am J Alzheimers Dis Other Demen. 2003 Sep-Oct;18(5):265-72. doi: 10.1177/153331750301800508. Am J Alzheimers Dis Other Demen. 2003. PMID: 14569643 Free PMC article. Clinical Trial.
-
Brief review: rivastigmine, a second cholinesterase inhibitor.Can J Neurol Sci. 2001 Feb;28 Suppl 1:S122-3. doi: 10.1017/s0317167100001293. Can J Neurol Sci. 2001. PMID: 11237306 Review. No abstract available.
Cited by
-
On the inhibitory affect of some dementia drugs on DNA polymerase Beta activity.Neurochem Res. 2008 Nov;33(11):2187-96. doi: 10.1007/s11064-007-9587-3. Epub 2008 Jan 10. Neurochem Res. 2008. PMID: 18185993
-
Cholinesterase inhibitors and vascular dementia: another string to their bow?CNS Drugs. 2004;18(2):79-92. doi: 10.2165/00023210-200418020-00002. CNS Drugs. 2004. PMID: 14728055 Review.
-
Rivastigmine in the treatment of Alzheimer's disease: an update.Clin Interv Aging. 2007;2(1):17-32. doi: 10.2147/ciia.2007.2.1.17. Clin Interv Aging. 2007. PMID: 18044073 Free PMC article. Review.
-
Cholinergic dysfunction in vascular dementia.Curr Psychiatry Rep. 2005 Mar;7(1):18-26. doi: 10.1007/s11920-005-0019-2. Curr Psychiatry Rep. 2005. PMID: 15717981 Review.
-
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.Clin Interv Aging. 2017 Apr 18;12:697-707. doi: 10.2147/CIA.S129145. eCollection 2017. Clin Interv Aging. 2017. PMID: 28458525 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources